• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Amgen

edit

Amgen Inc.. The Group’s principal activities are to discover, develop, manufacture and market human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of hematology, oncology and inflammation. The Group’s key products include Aranesp(R) (darbepoetin alfa), EPOGEN(R) (Epoetin alfa), Neulasta(R) (pegfilgrastim), NEUPOGEN(R) (Filgrastim) and Enbrel(R) (etanercept) stimulate the production of red blood cells, for the treatment of anemia associated with chronic renal failure. Neulasta(R) and NEUPOGEN(R) selectively stimulate the production of neutrophils, one type of white blood cell, for treatment of infection in-patients undergoing myelosuppressive chemotherapy. ENBREL(R) blocks the biologic activity of tumor necrosis factor, which is used for treating patients with active rheumatoid arthritis

Recent Milestones

edit

• 
  Amgen invested in Gamida Cell. (5/15/12)
  Posted 5/15/12 at 6:10pm via finsmes.com
• 
  Amgen acquired KAI Pharmaceuticals for $315M. (4/10/12)
  Posted 4/10/12 at 5:50pm via fiercebiotech.com
• 
  Amgen acquired BioVex for $1B. (1/25/11)
  Posted 1/25/11 at 9:51pm via masshightech.com
• 
  Amgen — Amgen, has reached agreement to acquire BioVex Group Inc. for what could total $1 billion (1/25/11)
  Posted 1/25/11 at 7:35am via masshightech.com
• 
  Amgen — Amgen pays Nektar $50M for polymer (11/2/10)
  Posted 11/2/10 at 7:23pm via fiercebiotech.com
• 
  Amgen added Sai Ram as Therapeutic Area Nephrology. (1/1/09)
  Posted 5/4/13 at 10:31pm
• 
  Amgen acquired Avidia for $380M. (10/2/08)
  Posted 9/16/09 at 1:25am via venturebeat.com
• 
  Amgen acquired Ilypsa for $420M. (6/5/07)
  Posted 9/20/09 at 1:26am via venturebeat.com
• 
  Amgen added Joe Sandoval as Business Planning Analyst. (1/1/07)
  Posted 5/16/12 at 7:53pm
• 
  Amgen added Neil Hughes as International Franchise Head, Bone & New Products &Marketing Exec Director . (9/1/04)
  Posted 5/3/13 at 9:58am
• 
  Amgen added Heather Franklin as Sr. Research Operations Program Manager. (1/1/98)
  Posted 4/16/13 at 11:00pm
• 
  Amgen added Lowell Sears as Senior Vice President & CFO. (8/1/86)
  Posted 4/22/13 at 12:05pm
• 
  Amgen added Mooky Desai as Technology Consultant.
  Posted 5/20/09 at 9:00am

Videos

Screenshots

edit

Above: Amgen Screenshot -- #1
Uploaded: 9/16/09

Sources

1. UPDATED: Amgen snags KAI Pharma's CKD program in $315M buyout (fiercebiotech.com) [edit]
2. BioVex to be acquired by Amgen for up to $1 billion (masshightech.com) [edit]
3. Amgen to buy inflammation drug co. Avidia for up to $380M (deals.venturebeat.com) [edit]
4. Amgen buys kidney-disease biotech Ilypsa for $420M (venturebeat.com) [edit]
5. Gamida Cell Closes $10m Series E Financing (finsmes.com) [edit]
Amgen pays Nektar $50M for polymer (fiercebiotech.com) [edit]
BioVex to be acquired by Amgen for up to $1 billion (masshightech.com) [edit]